During this one-on-one interview, Michael A. Evans, BS, RPh, of Geisinger Health System, discusses the use of warfarin as a treatment and/or prevention option for thromboembolic complications and explains why management of patients on warfarin is difficult.
Warfarin therapy, explains Mr Evans, requires frequent monitoring as warfarin is associated with numerous food interactions, drug-drug interactions, and disease interactions. Mr Evans also discusses warfarin’s mechanism of action and highlights specific foods, drugs, and conditions that affect the efficacy and safety of warfarin therapy.
Some patients prefer the frequent monitoring required with warfarin therapy, as it means more contact with healthcare providers; however, frequent visits for laboratory testing and monitoring place a burden on the healthcare system. As models of healthcare delivery change, patient access to care will become more challenging, says Mr Evans.
The number of testing and monitoring visits associated with warfarin therapy can potentially be reduced through the use of home INR monitoring devices, which allow patients to self-test and provide test results to their monitoring clinicians. However, the use of home INR monitoring devices is still resource utilization—intensive, notes Mr Evans.
The recent approval of direct-acting oral anticoagulants can benefit patient and clinicians, as these agents do not require routine monitoring, adds Mr Evans.
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Study Highlights Disparities in Access to In-Network Mental Health Care vs Medical Care
April 17th 2024While health plans often employ reimbursement rates as a tool to incentivize provider participation within their networks, study results showed reimbursement rates for office visits with medical/surgical clinicians were on average 22% higher than behavioral health clinicians.
Read More